Erratum
After publication of this work [1] it was noticed that there was a typographical error in the Conclusions. The letter ‘a’ in ‘asymtoptomatic’ should have been removed in the concluding statement as it is inconsistent with the Results and Discussion. The statement in the Conclusions should read: ‘Patients who were symptomatic placed significantly more importance on delaying an SSE when expressing medication preferences.’
The original article was corrected. The publisher apologises for this error.
Reference
Uemura H, Matsubara N, Kimura G, Yamaguchi A, Ledesma DA, DiBonaventura M, et al. Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment. BMC Urol. 2016;16:63.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s12894-016-0182-2.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Uemura, H., Matsubara, N., Kimura, G. et al. Erratum to: Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment. BMC Urol 17, 20 (2017). https://doi.org/10.1186/s12894-017-0210-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12894-017-0210-x